A perspective on the diagnosis of preterm labor

Journal of Perinatal and Neonatal Nursing

Volumn 16, Issue 1, 2002, Pages 1-11

  Abrahams, Carol ^a   Katz, Michael ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Preterm labor diagnosis; Preterm labor triage

Indexed keywords

EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; METHODOLOGY; NEWBORN NURSING; NURSING; NURSING DIAGNOSIS; PREGNANCY; PREMATURE LABOR; REVIEW; RISK ASSESSMENT;

FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; NEONATAL NURSING; NURSING DIAGNOSIS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RISK ASSESSMENT; TRIAGE;

EID: 0036596238     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005237-200206000-00003     Document Type: Article

References (30)

1. National Center for Health Statistics. Births: Final Data for 1998. National Vital Statistics Reports. 2000;48:1-2.
2. Creasy RK, Iams JD. Preterm labor and delivery. In: Creasy R, Resnik R, eds. Maternal-Fetal Medicine. 4th ed. Philadelphia: W.B. Saunders; 1999.
3. Blanco J. Clinical problem of preterm labor. Clin Obstet Gynecol. 2000;43:5-7.
4. St. John EB, Nelson KG, Cliver SP, et al. Cost of neonatal care according to gestational age at birth and survival status. Am J Obstet Gynecol. 2000;182:170-175.
5. Harbert GM Jr. Efforts to reduce low birth weight and preterm births: a statewide analysis. Am J Obstet Gynecol. 1994;171:329-338.
6. Lockwood CJ, Dudenhausen JW. New approaches to the prediction of preterm delivery. J Perinatol Med. 1993;21:441-452.
7. Canadian Preterm Labor Investigators Group. The treatment of preterm labor with beta-adrenergic agonist ritodrine. N Engl J Med. 1992;327:308-312.
8. Creasy RK, Katz M. Beta-adrenergic tocolytics: basic research and clinical experience in the United States. In: Fuchs F. Stubblefield PG, eds. Preterm Birth: Causes, Prevention and Management. New York: Macmillan; 1984.
9. Merkatz IR, Peter JB, Borden TP. Ritodrine hydrochloride: a betamimetic agent for use in preterm labor: II. Evidence of efficacy. Obstet Gynecol. 1980;56:7-12.
10. Goldenberg RL, Ohn CH, Auth MD, et al. Intrauterine infection and preterm delivery. N Engl J Med. 2000;342:1500-1507.
11. Lu GC, Goldenberg RL. Current concepts on the pathogenesis and markers of preterm births. Clin Perinatol. 2000;27:263-283.
12. Lockwood CJ, Kuczynski E. Markers of risk for preterm delivery. J Perinatol Med. 1999;27:5-20.
13. Katz M, Newman RB, Gill PJ. Assessment of uterine activity in ambulatory patients at high risk of preterm labor. Am J Obstet Gynecol. 1986;154:44-47.
14. Katz M, Goodyear K, Creasy RK. Early signs and symptoms of preterm labor. Am J Obstet Gynecol. 1990;162:1150-1153.
15. Herron M, Katz M, Creasy RK. Evaluation of a preterm birth prevention program: preliminary report. Obstet Gynecol. 1982;59:452-456.
16. Main DM, Gabbe SG, Richardson D, et al. Can preterm births be prevented? Am J Obstet Gynecol. 1985;151:892-898.
17. Meis PJ, Ernest JM, Moore ML, et al. Regional program for prevention of premature birth in northwestern North Carolina. Am J Obstet Gynecol. 1987;157: 550-556.
18. Katz M, Gill PJ, Newman RB. Detection of preterm labor by ambulatory monitoring of uterine activity: a preliminary report. Obstet Gynecol. 1986;68:773-778.
19. Morrison JC, Martin JN, Martin RW, et al. Prevention of preterm birth by ambulatory assessment of uterine activity: a randomized study. Obstet Gynecol. 1987;156: 536-543.
20. Dyson DC, Crites YM, Ray DA, et al. Prevention of preterm birth in high-risk patients: the role of education and provider contact versus home uterine monitoring. Am J Obstet Gynecol. 1991;154:756-762.
21. Iams JD, Newman RB, Thom EA, et al. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med. 2002;346:250-255.
22. Iams JD. Obstetric inertia: an obstacle to the prevention of prematurity. Am J Obstet Gynecol. 1988;159:796-799.
23. Farkouh L, McGregor JA, Hobbins JC. Transport of ultrasound contrast medium from the vagina into the uterus in pregnant women at term. Presented at Second International Meeting on Bacterial Vaginosis; September 17-19, 1998; Aspen, CO.
24. Jung H, Lamberti G. Beta-mimetic drugs in obstetrics and perinatology. Presented at Third Symposium on Beta-Mimetic Drugs; November 1980, Aachen, Germany.
25. Creasy RK. Preterm labor and delivery. In: Creasy RK, Resnik R, eds. Maternal-Fetal Medicine. 2nd ed. Philadelphia: W.B. Saunders; 1989.
26. Andrews WW, Copper R, Hauth JC, et al. Second-trimester cervical ultrasound: associations with increased risk for recurrent early spontaneous delivery. Obstet Gynecol. 2000;95:222-226.
27. Berghella V, Daly SF, Tolosa JE, et al. Prediction of preterm delivery with transvaginal ultrasonography of the cervix in patients with high-risk pregnancies: does cerclage prevent prematurity? Obstet Gynecol. 1999;181:809-815.
28. Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions defines a patient population at high risk for preterm delivery. N Engl J Med. 1991;325:669-674.
29. Lopez RL, Francis JA, Garite TJ, et al. Fetal fibronectin detection as a predictor of preterm birth in actual clinical practice. Am J Obstet Gynecol. 2000;182:1103-1106.
30. Konte JM, Holbrook RH, Laros RK, Creasy RK. Short-term neonatal morbidity associated with prematurity and the effect of a prematurity prevention program on expected incidence of morbidity. Am J Perinatol. 1986;3:283-288.